ADRIAN GOTTSCHALK - 09 Apr 2025 Form 4 Insider Report for Foghorn Therapeutics Inc. (FHTX)

Role
Chief Executive Officer, Director
Signature
/s/ Michael LaCascia, Attorney-in-Fact for Adrian Gottschalk
Issuer symbol
FHTX
Transactions as of
09 Apr 2025
Net transactions value
$0
Form type
4
Filing time
10 Apr 2025, 16:01:26 UTC
Previous filing
24 Jan 2025
Next filing
28 Apr 2025
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction FHTX Common Stock Gift $0 -197,906 -28% $0.000000 511,704 09 Apr 2025 See Footnote F1, F2
transaction FHTX Common Stock Gift $0 +197,906 +63% $0.000000 511,704 09 Apr 2025 See Footnote F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 On April 9, 2025, the Adrian H. Gottschalk 2023 Grantor Retained Annuity Trust dated May 26, 2023, of which the Reporting Person is the trustee and sole current beneficiary (the "Gottschalk 2023 GRAT"), distributed 197,906 shares of the Issuer's Common Stock to the Adrian H. Gottschalk Living Trust dated September 8, 2009, of which the Reporting Person is the trustee (the "Gottschalk Living Trust").
F2 Consists of 47,497 shares held by the Gottschalk 2023 GRAT and 464,207 shares held by the Gottschalk Living Trust.